Unjha Formulations Ltd.
BSE: 531762 | Sector: Health care |
NSE: N.A. | ISIN Code: INE576D01015 |
BSE 00:00 | 02 Mar | 8.35 |
0.37 (4.64%) |
OPEN
7.60 |
HIGH
8.35 |
LOW
7.60 |
NSE 05:30 | 01 Jan | Unjha Formulations Ltd |
OPEN | 7.60 |
PREVIOUS CLOSE | 7.98 |
VOLUME | 2560 |
52-Week high | 10.26 |
52-Week low | 5.20 |
P/E | 52.19 |
Mkt Cap.(Rs cr) | 4 |
Buy Price | 7.60 |
Buy Qty | 25.00 |
Sell Price | 8.35 |
Sell Qty | 115.00 |
Unjha Formulations Ltd. (UNJHAFORMUL) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 614.40 | 147,412.99 | 12,531.93 | 3,211.14 | 32,355.78 |
Divi's Lab. | 3,515.55 | 93,320.28 | 5,310.57 | 1,372.71 | 7,370.84 |
Dr Reddy's Labs | 4,406.20 | 73,275.11 | 11,850.40 | 2,937.70 | 16,732.90 |
Cipla | 812.10 | 65,491.80 | 12,659.15 | 2,318.17 | 17,704.77 |
Aurobindo Pharma | 886.75 | 51,954.68 | 13,266.48 | 1,872.74 | 16,809.46 |
Lupin | 1,054.60 | 47,841.93 | 11,025.66 | 727.55 | 17,937.29 |
Biocon | 397.75 | 47,730.00 | 1,988.40 | 440.90 | 7,583.50 |
Cadila Health. | 440.95 | 45,140.05 | 6,347.40 | 1,412.90 | 15,089.80 |
Apollo Hospitals | 3,089.75 | 44,424.43 | 9,794.50 | 470.30 | 8,570.00 |
Piramal Enterp. | 1,918.00 | 43,260.49 | 4,219.19 | 144.85 | 33,415.39 |
Torrent Pharma. | 2,468.95 | 41,779.57 | 6,168.44 | 938.51 | 10,683.66 |
Gland Pharma | 2,349.95 | 38,421.68 | 2,633.24 | 772.86 | 3,653.86 |
Alkem Lab | 2,910.15 | 34,790.84 | 6,677.08 | 1,264.42 | 7,728.19 |
Abbott India | 14,522.20 | 30,859.68 | 4,093.14 | 592.93 | 2,691.43 |
Glaxosmi. Pharma | 1,467.10 | 24,854.14 | 3,224.68 | 110.05 | 2,129.60 |
Ipca Labs. | 1,906.15 | 24,179.51 | 4,367.43 | 652.46 | 4,185.23 |
Syngene Intl. | 552.65 | 22,106.00 | 2,011.90 | 411.50 | 3,313.70 |
Pfizer | 4,655.90 | 21,300.74 | 2,151.65 | 509.13 | 3,534.54 |
Dr Lal Pathlabs | 2,332.10 | 19,435.72 | 1,273.60 | 223.18 | 1,106.64 |
Laurus Labs | 362.05 | 19,427.60 | 2,797.34 | 267.05 | 2,966.39 |
Quick Links for Unjha Formulations:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices